EquityBulls

Latest News

Keywords Selected: BioPharm

Stock Report

Indegene announces acquisition of BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma
OneSource and Xbrane Biopharma Announce Biosimilars Manufacturing Partnership for the Global Markets
Emcutix and WiQo Sign Exclusive Licensing Partnership to Revolutionize Derma-cosmetic Treatments in India
Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI
BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK
Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power
Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group
Cipla EU Ltd to form JV in USA
Stelis Biopharma updates on receipt of consideration from Syngene
Stelis Biopharma announces closure of its transaction with Syngene International Ltd
Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd
Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta™ for ChemotherapyInduced Neutropenia
Stelis Biopharma enters into a binding term sheet with Syngene International Ltd to divest its Unit 3 multi-modal facility
Stelis Biopharma's flagship facility receives EIR from the USFDA
Stelis Biopharma's CDMO partner receives approval for a key ANDA from the USFDA
Evive Enters License Agreement with Acrotech Biopharma to Commercialize Ryzneuta™ in the United States
Stelis receives a positive recommendation from EMA granting market authorization for Kauliv™
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A
Stelis Biopharma's flagship facility receives USFDA nod for Drug Product Capabilities
Orchid Pharma Ltd updates on PLI scheme benefits for its subsidiary
Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement
Stelis Biopharma Ltd commissions vaccine manufacturing facility at Bengaluru